ArticleCancers2022

Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients' Blood.

Paul Friedrich Geus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.